| Sylvia Gayle Fischer, CNS | |
|
301 Becker Ave Sw, Willmar, MN 56201-3302 | |
| (320) 231-8770 | |
| (320) 231-8741 |
| Full Name | Sylvia Gayle Fischer |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Adult Health |
| Location | 301 Becker Ave Sw, Willmar, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215091319 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2200X | Clinical Nurse Specialist - Adult Health | R 077675-8 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sylvia Gayle Fischer, CNS 48484 Watkins Rd, Big Stone City, SD 57216-8210 Ph: (605) 862-8693 | Sylvia Gayle Fischer, CNS 301 Becker Ave Sw, Willmar, MN 56201-3302 Ph: (320) 231-8770 |
News Archive
In a vertical climb to avoid collision with a towering mountain, a plane ejects cargo to gain altitude. Investigators at the University of Minnesota showed that cancer cells perform similar feats in escaping the killing effects of radiation.
Endovascular or endograft repair, a minimally invasive interventional radiology treatment that uses stent grafts to treat abdominal aortic aneurysms (AAA), has low re-intervention rates that are comparable to those reported for open surgical repair-and can be recommended as first-line treatment, according to a study released at the Society of Interventional Radiology's 34th Annual Scientific Meeting.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that based on information provided by PharmAthene in its compliance plan, and discussions with Exchange staff, the NYSE Amex LLC has determined that the Company made a reasonable demonstration of its ability to regain compliance with the NYSE Amex listing requirements and granted PharmAthene an extension until January 26, 2012 to demonstrate its compliance.
In the most comprehensive look at genetic risk factors for type 2 diabetes to date, a U.S.-Finnish team, working in close collaboration with two other groups, has identified at least four new genetic variants associated with increased risk of diabetes and confirmed existence of another six.
NuGEN Technologies, the provider of innovative RNA and DNA amplification and sample preparation technologies for genomic analysis, today announced it has been selected by the National Heart, Lung, and Blood Institute (NHLBI) to provide automated reagent solutions for expression profiling of approximately 6,000 blood samples from the Framingham Heart Study.
› Verified 2 days ago
Mrs. Kristel Marlena Hart, RN, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1125 Se 6th St, Willmar, MN 56201 Phone: 320-235-4613 Fax: 320-231-9141 | |
Mrs. Aimee Lyn Tebrake, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 502 2nd St Sw, Willmar, MN 56201 Phone: 320-235-7232 Fax: 320-231-8609 |